NZ574216A - Treatment of cartilage disorders with fgf-18 - Google Patents

Treatment of cartilage disorders with fgf-18

Info

Publication number
NZ574216A
NZ574216A NZ574216A NZ57421607A NZ574216A NZ 574216 A NZ574216 A NZ 574216A NZ 574216 A NZ574216 A NZ 574216A NZ 57421607 A NZ57421607 A NZ 57421607A NZ 574216 A NZ574216 A NZ 574216A
Authority
NZ
New Zealand
Prior art keywords
lys
arg
leu
thr
val
Prior art date
Application number
NZ574216A
Other languages
English (en)
Inventor
Alberto Gimona
Christoph H Ladel
Baur Elmar Vom
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Priority claimed from PCT/EP2007/058830 external-priority patent/WO2008023063A2/en
Publication of NZ574216A publication Critical patent/NZ574216A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ574216A 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18 NZ574216A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06119557 2006-08-25
US84060006P 2006-08-28 2006-08-28
PCT/EP2007/058830 WO2008023063A2 (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18

Publications (1)

Publication Number Publication Date
NZ574216A true NZ574216A (en) 2011-11-25

Family

ID=37684849

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ574216A NZ574216A (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18

Country Status (11)

Country Link
CN (1) CN101505787B (sl)
BR (1) BRPI0715728A8 (sl)
DK (1) DK2054050T3 (sl)
ES (1) ES2392883T3 (sl)
MY (1) MY148277A (sl)
NZ (1) NZ574216A (sl)
PT (1) PT2054050E (sl)
RS (1) RS52710B (sl)
SI (1) SI2054050T1 (sl)
UA (1) UA99818C2 (sl)
ZA (1) ZA200900426B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10221456B2 (en) * 2012-08-06 2019-03-05 Merck Patent Gmbh Genetic markers for predicting responsiveness to FPG-18 compound
EP3107592B1 (en) * 2014-02-20 2018-08-22 Merck Patent GmbH Implant comprising fgf-18
US20170056554A1 (en) * 2014-02-20 2017-03-02 Merck Patent Gmbh Fgf-18 in graft transplantation and tissue engineering procedures
AR099510A1 (es) * 2014-02-20 2016-07-27 Merck Patent Gmbh Régimen de dosaje del compuesto fgf-18
EP3250223A1 (en) * 2015-01-08 2017-12-06 University of Iowa Research Foundation Methods for the regeneration of articular cartilage in vivo
JP6951318B2 (ja) * 2015-07-15 2021-10-20 プロージット ソウル バイオテクノロジー （ベイジン） カンパニー リミテッド 融合ポリペプチドおよび使用方法
WO2017025611A1 (en) * 2015-08-13 2017-02-16 Merck Patent Gmbh Combination composition comprising fgf-18 compound
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN117721115A (zh) * 2022-09-06 2024-03-19 深圳瑞吉生物科技有限公司 用于治疗骨关节炎的mRNA及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4754823B2 (ja) * 2002-10-07 2011-08-24 ザイモジェネティクス， インコーポレイテッド Ｆｇｆ１８の投与方法
EP1896053B1 (en) * 2004-07-06 2018-10-31 ZymoGenetics, Inc. Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
CA2592261C (en) * 2004-12-10 2015-11-24 Zymogenetics Inc. Fgf18 production in prokaryotic hosts

Also Published As

Publication number Publication date
SI2054050T1 (sl) 2012-12-31
PT2054050E (pt) 2012-09-17
ZA200900426B (en) 2010-04-28
UA99818C2 (ru) 2012-10-10
BRPI0715728A8 (pt) 2018-04-03
RS52710B (en) 2013-08-30
ES2392883T3 (es) 2012-12-14
MY148277A (en) 2013-03-29
BRPI0715728A2 (pt) 2013-09-17
DK2054050T3 (da) 2012-09-03
CN101505787B (zh) 2013-09-04
CN101505787A (zh) 2009-08-12

Similar Documents

Publication Publication Date Title
CA2658511C (en) Use of fgf-18 compound to treat cartilage disorders
NZ574216A (en) Treatment of cartilage disorders with fgf-18
DK3119417T3 (en) Dosage schedule for FGF-18 compound
RU2745453C2 (ru) Комбинированная композиция, содержащая соединение fgf-18
KR20190112053A (ko) 치료 조성물
JP2007516223A (ja) 新規線維芽細胞成長因子及びその使用方法

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 24 AUG 2017 BY CPA GLOBAL

Effective date: 20140710

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 AUG 2018 BY CPA GLOBAL

Effective date: 20170713

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 AUG 2019 BY CPA GLOBAL

Effective date: 20180712

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 AUG 2020 BY CPA GLOBAL

Effective date: 20190712

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 AUG 2021 BY CPA GLOBAL

Effective date: 20200709

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 AUG 2022 BY CPA GLOBAL

Effective date: 20210708

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 AUG 2023 BY COMPUTER PACKAGES INC

Effective date: 20220817

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 AUG 2024 BY COMPUTER PACKAGES INC

Effective date: 20230730